Submitted by: Submitted by xtremedesicanuck
Views: 1353
Words: 2908
Pages: 12
Category: Business and Industry
Date Submitted: 01/30/2011 03:40 PM
[pic]
Boston Consulting Group
Name: James Kinsley
ID: 5811732
Date: October 15, 2010
Presented to: Howie Pun
Course: Management 401
TABLE OF CONTENTS
INTRODUCTION 1
Situation Synopsis 1
Problem Statement 1
ANALYSIS 1
EXTERNAL ANALYSIS 1
Industry Structure 2
Industry Direction and Trends 2
Competitive Situation Analysis 3
Competitive Forces (Porter) 3
Competitor Analysis 3
INTERNAL ANALYSIS 4
Primary Activities (Value Chain Analysis) 4
R&D Analysis 5
Financial Analysis 5
EVALUATION OF ALTERNATIVES 5
Alternative Strategy 5
Alternative 1: Focus on Geographical Diversification 5
Alternative 2: Exploration of Niche and Biosimilars 5
Recommendation 6
Implementation 6
APPENDICES 7
Exhibit 1-3 7
Exhibit 4-5 8
Exhibit 6-7 9
BIBLIOGRAPHY 10
INTRODUCTION
Situation Synopsis
With markets opening up in developing countries, Teva will be embraced with new opportunities and ventures as well as serious threats from local low cost firms. Novartis one of many competitors of Teva has increased its presence with strategic acquisitions of generic firms that have the potential to further negatively impact the value of Teva’s share prices.
Problem Statement
As one of the largest firms in generic drugs manufacturing, Teva Pharmaceuticals will be faced with threats by firms from different segments of the pharmaceutical industry. In order to survive in this competitive industry, it must review its current strategy and be prepared to implement a revised one. Threats from global innovative firms, low-cost...